Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Eupraxia Pharmaceuticals (NASDAQ: EPRX) Advances EoE Treatment Pipeline with RESOLVE Trial Data

RESOLVE Trial Data Signals Dose-Dependent Clinical Improvement

Nitish Kishor | 05 May 2026

MPLX Misses Estimates as Volume Headwinds Overshadow Strong EBITDA and Distribution Growth

MPLX LP (NYSE:MPLX) Q1 2026 EPS of USD 0.90 missed the consensus by 15%, with revenue of USD 3.04 billion falling short of forecasts, as pipeline volume declines and NGL price headwinds weighed on results despite adjusted EBITDA of USD 1.7 billion and a …

Nitish Kishor | 05 May 2026

The USD 25,000 Day Trading Barrier Is Gone. The Risks Are Not.

FINRA eliminates the USD 25,000 Pattern Day Trader rule effective June 4, 2026, replacing it with a real-time intraday margin framework under amended Rule 4210. Here is what changes, what does not, and what it means for retail market structure.Key HighlightsFINRA eliminates the Pattern …

Nitish Kishor | 05 May 2026
Support

Hi! How can we help you today?

Loading…